Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | RECQL | P46063 | 2/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | MAOA | P21397 | 2/20 | 0.61 |
| ▸ | MAOB | P27338 | 2/20 | 0.61 |
| ▸ | BCHE | P06276 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | ACHE | P22303 | 1/20 | 0.61 |
| ▸ | APEX1 | P27695 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | CASP1 | P29466 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.61 |
| ▸ | DHODH | Q02127 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.61 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL113494 | 0.88 | — | — | |
| Water SCHEMBL27949772 | 0.84 | — | — | |
| Ammonia Solution, Strong SCHEMBL8627775 | 0.84 | MAOA (0.36) | ALDH1A1RECQLTDP1MAOAMAOB | |
| Potassium SCHEMBL30715495 | 0.84 | — | — | |
| SCHEMBL30715500 | 0.84 | — | — | |
| SCHEMBL9149406 | 0.84 | — | — | |
| Formaldehyde SCHEMBL27513797 | 0.80 | MAOA (0.33) | ALDH1A1RECQLTDP1MAOAMAOB | |
| Benzene SCHEMBL28145502 | 0.80 | MAOA (0.37) | ALDH1A1RECQLTDP1MAOAMAOB | |
| Nitrogen SCHEMBL27904925 | 0.80 | MAOA (0.33) | ALDH1A1RECQLTDP1MAOAMAOB | |
| SCHEMBL106540 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4981946-A | Marine paint composition comprising quinone/polyamine polymer | ERHAN SEMIH (US) | 1991-01-01 | — | — | US | claimed |
| US-20210322337-A1 | TREATMENT OF OXIDATIVE STRESS DISORDERS INCLUDING CONTRAST NEPHROPATHY, RADIATION DAMAGE AND DISRUPTIONS IN THE FUNCTION OF RED CELLS | PTC THERAPEUTICS, INC. | 2021-10-21 | — | — | US | disclosed |
| US-20180303767-A1 | TREATMENT OF OXIDATIVE STRESS DISORDERS INCLUDING CONTRAST NEPHROPATHY, RADIATION DAMAGE AND DISRUPTIONS IN THE FUNCTION OF RED CELLS | BIOELECTRON TECHNOLOGY CORPORATION (US) | 2018-10-25 | — | — | US | disclosed |
| US-10039722-B2 | Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells | BIOELECTRON TECHNOLOGY CORPORATION (US) | 2018-08-07 | — | — | US | disclosed |
| US-8795858-B2 | Magnetic recording medium and method of manufacturing the same | FUJIFILM CORPORATION (JP) | 2014-08-05 | — | — | US | disclosed |
| US-8552572-B2 | Resin composition for encapsulating semiconductor and semiconductor device using the same | SUMITOMO BAKELITE CO., LTD. (JP) | 2013-10-08 | — | — | US | disclosed |
| US-20110269776-A1 | TREATMENT OF OXIDATIVE STRESS DISORDERS INCLUDING CONTRAST NEPHROPATHY, RADIATION DAMAGE AND DISRUPTIONS IN THE FUNCTION OF RED CELLS | EDISON PHARMACEUTICALS, INC. (US) | 2011-11-03 | — | — | US | disclosed |
| US-20110229741-A1 | MAGNETIC RECORDING MEDIUM AND METHOD OF MANUFACTURING THE SAME | FUJIFILM CORPORATION (JP) | 2011-09-22 | — | — | US | disclosed |
| EP-2362726-A1 | TREATMENT OF OXIDATIVE STRESS DISORDERS INCLUDING CONTRAST NEPHROPATHY, RADIATION DAMAGE AND DISRUPTIONS IN THE FUNCTION OF RED CELLS | Edison Pharmaceuticals, Inc. (US) | 2011-09-07 | — | — | EP | disclosed |
| US-20110124775-A1 | RESIN COMPOSITION FOR ENCAPSULATING SEMICONDUCTOR AND SEMICONDUCTOR DEVICE USING THE SAME | SUMITOMO BAKELITE CO., LTD (JP) | 2011-05-26 | — | — | US | disclosed |
| WO-2010045220-A1 | TREATMENT OF OXIDATIVE STRESS DISORDERS INCLUDING CONTRAST NEPHROPATHY, RADIATION DAMAGE AND DISRUPTIONS IN THE FUNCTION OF RED CELLS | EDISON PHARMACEUTICALS, INC. (US) | 2010-04-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110269776-A1 | TREATMENT OF OXIDATIVE STRESS DISORDERS INCLUDING CONTRAST NEPHROPATHY, RADIATION DAMAGE AND DISRUPTIONS IN THE FUNCTION OF RED CELLS | GPX4, TXN2, TXNRD1 | ALDH1A1 386/4885RECQL 997/4885TDP1 2191/4885 |
| US-20180303767-A1 | TREATMENT OF OXIDATIVE STRESS DISORDERS INCLUDING CONTRAST NEPHROPATHY, RADIATION DAMAGE AND DISRUPTIONS IN THE FUNCTION OF RED CELLS | GPX4, TXN2, TXNRD1 | ALDH1A1 386/4885RECQL 997/4885TDP1 2191/4885 |
| US-10039722-B2 | Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells | GPX4, TXN2, TXNRD1 | ALDH1A1 386/4885RECQL 997/4885TDP1 2191/4885 |
| US-20210322337-A1 | TREATMENT OF OXIDATIVE STRESS DISORDERS INCLUDING CONTRAST NEPHROPATHY, RADIATION DAMAGE AND DISRUPTIONS IN THE FUNCTION OF RED CELLS | GPX4, TXN2, TXNRD1 | ALDH1A1 386/4885RECQL 997/4885TDP1 2191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.